605507 國邦醫藥
按盤價 
24.250 -1.610 (-6.226%) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 1,520,880 | 5.61% | 6,011,397 | 5,890,839 | 5,349,448 | 5,720,925 | |
| 減：營業總成本 | 1,334,912 | 10.41% | 5,101,192 | 5,007,121 | 4,654,821 | 4,664,769 | |
| 其中:營業成本 | 1,170,111 | 10.46% | 4,446,533 | 4,418,113 | 4,097,119 | 4,144,882 | |
| 財務費用 | 22,726 | -561.95% | 20,649 | (29,817) | (46,282) | (68,011) | |
| 資產減值損失 | (3,244) | -178.14% | (27,022) | (25,825) | (31,447) | (27,706) | |
| 公允價值變動收益 | 4,430 | 4.73% | 12,923 | 14,402 | 10,342 | 4,558 | |
| 投資收益 | 2,709 | -3.52% | 16,993 | 12,948 | 13,221 | 19,537 | |
| 其中：對聯營企業和合營企業的投資收益 | (1,758) | -10.27% | (6,366) | (2,812) | 60 | (745) | |
| 營業利潤 | 187,940 | -24.36% | 963,994 | 895,067 | 702,263 | 1,052,878 | |
| 利潤總額 | 187,173 | -24.78% | 951,260 | 887,970 | 697,649 | 1,035,639 | |
| 減：所得稅費用 | 27,045 | -21.77% | 133,686 | 107,392 | 87,670 | 115,017 | |
| 淨利潤 | 160,129 | -25.26% | 817,574 | 780,577 | 609,979 | 920,622 | |
| 減：非控股權益 | (501) | -30.16% | (3,247) | (1,018) | (2,485) | (282) | |
| 股東淨利潤 | 160,630 | -25.28% | 820,820 | 781,595 | 612,464 | 920,904 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.290 | -23.68% | 1.480 | 1.400 | 1.100 | 1.650 | |
| 每股派息 (元) * | -- | -- | 0.600 | 0.606 | 0.302 | 0.600 | |
| 每股淨資產 (元) * | 15.593 | 5.55% | 15.306 | 14.401 | 13.299 | 12.804 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 16/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
